Anti-o2 antibodies and uses thereof
US-2025368723-A1 · Dec 4, 2025 · US
Kaplan Gilad is listed as an inventor on 13 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Kaplan Gilad |
| Total patents | 13 |
| First publication | Jul 23, 2020 |
| Latest publication | Dec 4, 2025 |
Publications ranked by popularity score, then publication date.
US-2025368723-A1 · Dec 4, 2025 · US
US-12486316-B1 · Dec 2, 2025 · US
US-2025289871-A1 · Sep 18, 2025 · US
US-12312397-B2 · May 27, 2025 · US
US-2025115678-A1 · Apr 10, 2025 · US
US-2024383969-A1 · Nov 21, 2024 · US
US-12018068-B2 · Jun 25, 2024 · US
US-2023079661-A1 · Mar 16, 2023 · US
US-11447542-B2 · Sep 20, 2022 · US
US-2022056113-A1 · Feb 24, 2022 · US
Latest publications not already listed above.
US-11117956-B2 · Sep 14, 2021 · US
US-2021238263-A1 · Aug 5, 2021 · US
US-2020231660-A1 · Jul 23, 2020 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Medimmune Llc | 10 |
| Humabs Biomed Sa | 10 |
| Astrazeneca Uk Ltd | 2 |
| Astrazeneca Ab | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K2039/505 | 13 |
| C07K2317/76 | 12 |
| C07K2317/565 | 10 |
| A61K31/407 | 10 |
| A61P31/04 | 10 |